E-mail us:
service@prospectnews.com
Or call: 212 374 2800
Bank Loans - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
Add to balance / Manage account
Not logged in
Prospect News home
>
Main news index
>
All issuers starting with C
>
Issuers starting with C, PP only
>
All stories on Cellceutix Corp.
>
Stories on Cellceutix Corp., PP only
Search again
Enter part or all of the issuer name:
Market:
All markets
No structured products
Bank loans
Canadian bonds
CLOs
Convertibles
Distressed debt
Emerging markets
High yield
Investment grade
Liability management
Municipals
PIPEs
Preferreds
Private placements
All leveraged markets
Structured products
Market: BK = Bank loans, CV = Convertibles, DD = Distressed Debt, EM = Emerging Markets, HY = High Yield, IG = Investment Grade, LM = Liability Management, MU = Municipals, PP = PIPEs, PF = Preferreds, PV = Private Placements, SP = Structured Products
Recent items, highlighted in orange, are $4.00 each.
All others are $1.00 each. Headlines in
gray
are not currently covered by your subscription.
Cellceutix Corp.
3/31/2015
PP
Cellceutix to conduct $30 million common stock purchase agreement
10/28/2013
PP
Cellceutix secures $20 million via common stock purchase agreement
1/8/2013
PP
Cellceutix cancels remainder of $1 million preferred stock placement
12/10/2012
PP
Cellceutix secures $10 million through common stock purchase agreement
5/10/2012
PP
Cellceutix wraps $100,000 of $1 million placement of preferred stock
11/8/2011
PP
Cellceutix completes $333,000 tranche of $1 million placement of units
©2025 Prospect News. This page is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.
